Werfen acquires Omixon

16/10/2024
Barcelona, Spain May 15, 2024.- Werfen announced today that it has agreed to acquire Omixon, a privately held corporation with an innovative portfolio in transplant diagnostics headquartered in Budapest, Hungary. The acquisition will allow Werfen to expand its portfolio of transplant diagnostics solutions for hospitals and clinical laboratories.

 

Read more

Werfen to acquire Omixon expanding its portfolio in transplant diagnostics

15/05/2024
Barcelona, Spain May 15, 2024.- Werfen announced today that it has agreed to acquire Omixon, a privately held corporation with an innovative portfolio in transplant diagnostics headquartered in Budapest, Hungary. The acquisition will allow Werfen to expand its portfolio of transplant diagnostics solutions for hospitals and clinical laboratories.

 

Read more

BSHI 2022

22/07/2022
  BSHI 2022 | British Society for Histocompatibility and Immunogenetics Conference | 13-14 Sept, 2022, London, UK    The opportunity to meet us again is open, as Omixon team will be present at the 32nd  Annual British Society for Histocompatibility and Immunogenetics Conference in London, UK. Our experts are looking...

 

Read more

New Year Address from the CEO

07/01/2021
Year 2020 will enter the history books described as unprecedented, remarkable, extraordinary, or once-in-a lifetime challenge for humanity.  All of us suffered from the restrictions introduced to suppress viral transmission. Many of us had loved ones affected or lost to COVID. Scientist lacked opportunities to meet, discuss and debate...

 

Read more

Omixon Launches AzureSeq-200 CE IVD Kit For One-step RT-qPCR Detection of SARS-CoV-2 and Announces Exclusive Agreement with SeqOnce Biosciences

05/10/2020
As much as Omixon wants to stay focused on the needs of histocompatibility labs, the current coronavirus pandemic calls for innovation in the field of viral detection based on molecular diagnostics. Omixon has used its product development capabilities and collaboration network to develop a truly innovative product addressing an...

 

Read more

Omixon Launches OmniType, Multiplex For NGS-based HLA Genotyping

30/09/2020
Omixon proudly announces the launch of OmniType, a 11-locus multiplex human leukocyte antigen (HLA) genotyping assay and software product for use on the Illumina® sequencing platforms (such as MiSeq, MiniSeq and iSeq). OmniType offers a revolutionary single working-day workflow that allows processing of samples from gDNA to a ready-to-sequence...

 

Read more

EWIC, March 5-7, 2020

02/03/2020
Omixon is one of the Platinum Sponsors of the EWIC 2020 Conference being held in Budapest, Hungary. Visit our booth and join our talk, titled “Genome-wide Approaches for Identification of Disease-Associated Gene Variants: Base Concepts and Examples” on Friday, March 6 from 13:05! EWIC 2020 website

 

Read more

Bionics Day, December 6, 2019

18/11/2019
Omixon is attending and exhibiting at the upcoming Bionics Day at Pázmány Péter Catholic University ITK on December 6, “where the Bionics Faculty, bionics students and bionics companies meet”. Read more about the event (English/Hungarian) and register here…

 

Read more

ASHI, September 23-27, 2019

06/09/2019
We are happy to invite everyone to our ABHI accredited events at ASHI 2019 in Pittsburgh, PA! This is what you can expect from us:   User Group Meeting – Monday, September 23, 2019 at 12:00pm- 4:30pm Venue: Room 333, David L. Lawrence Convention Center, Level 3   Join...

 

Read more

EFI, May 8-11, 2019

26/03/2019
Omixon is one of the Golden Sponsors of this year’s EFI Conference. Meet our team at our booth #16 and join us for our events: HLA Twin Live Software Demos at the Omixon booth Interactive User Group Meeting Lunchtime Symposium: Advances in Disease Associations Using NGS-based HLA Typing on...

 

Read more

EWIC, March 14-16, 2019

11/02/2019
We are happy to announce that Omixon is one of the Silver Sponsors of this year’s EWIC Conference in Zagreb, Croatia. Title of our talk: “Donor selection for solid organ transplantation guided by NGS high resolution HLA typing in combination with PIRCHE “ Date: Friday, March 15, 2019 Time:...

 

Read more

EFI, May 9-12, 2018

01/12/2017
Omixon is proud to be one of the Gold Sponsors of the upcoming EFI Conference in Venice, Italy! Meet our team at booth #15/16. Our events at the conference: Lunchtime Symposium: Holotyping without Borders – Holotype HLA V2. Experiences Within and from Outside the EU for the Benefit of...

 

Read more

AABB, October 7-10

01/02/2017
This year’s AABB Conference will take place in San Diego, California between October 7-10. Arrange a meeting with our US team by contacting us. Visit the AABB website here…

 

Read more

BSHI, October 3-4, 2017

01/02/2017
The Annual British Society of Histocompatibility and Immunogenetics Conference will be held in Leamington Spa, UK in October. Omixon is presenting a Lunchtime Workshop on October 3 at 12:30pm. Our Guest Speaker will be Dr. Brendan Clarke (Leeds St. James’s University Hospital). Topic of our presentation: EFI Accreditation with NGS...

 

Read more

Omixon Receives IVDR approval for NanoTYPE™ CE IVDR Pioneering Transplant Diagnostic with the First CE IVDR Kit based on Oxford Nanopore Technologies

11/06/2024
Press Release June 11, 2024 Budapest, Hungary   Omixon Receives IVDR approval for NanoTYPE™ CE IVDR Pioneering Transplant Diagnostic with the First CE IVDR Kit based on Oxford Nanopore Technologies   Omixon has received In Vitro Diagnostic Regulation (IVDR) approval of NanoTYPE™, an innovative high resolution multiplex 11 loci...

 

Read more

Omixon at EFI 2024 Geneva

25/04/2024
Excitement is building as we gear up for this year’s EFI Conference in Geneva. Year after year EFI serves as a dynamic platform for exchanging ideas, networking, and exploring collaborations that can drive the field forward. Be sure to visit the Omixon booth first to see NanoTYPE and NanoTYPER...

 

Read more